Pharmaceutical Products
Description
High Quality Tofacitinib (CP-690550, Tasocitinib) Research Only
(CAS 477600-75-2)
Product Description:
Tofacitinib (trade names Xeljanz and Jakvinus, formerly tasocitinib,CP-690550) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and other countries. It has demonstrated effectiveness in the treatment of psoriasis in Phase 3 studies. It is being studied for treatment of inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection.
CONTACT US:
Telephone +86-027-87002705
Mobile +86-13277093700
Skype newbiopharmtech
FaceBook Page https://www.facebook.com/newbiopharma/
Facebook Group https://www.facebook.com/groups/1739616069613416/
Website http://www.newbiopharm.com/
Online Store http://biocar.en.made-in-china.com/
Read More
Wuhan Biocar Bio-pharm Co., Ltd
Fluconazole Paclitaxel Chlorpheniramine maleate Clotrimazole Itraconazole Abamectin Pidotimod Ciprofloxacin hydrochloride Terbinafine Hydrochloride Linocaine hydrochloride Tigecycl
Address: 858, East Lake, High-Tech Development Zone, ,
Wuhan, , Hubei,
China,
Tel: +86-13277093700
Fax:
